NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Merlin Biotech

Merlin Biotech

Private
Doylestown, PennsylvaniaHealthcare & Life Scienceshttps://www.merlinbiotech.com/

Last Round

Early Funding

Feb 11, 2025

Total Funding Raised

$225,000

Company Overview

Merlin Biotech is a biotechnology company that applies proven mRNA technology for the development of novel therapeutics and vaccines for diseases such as cancer, chronic hepatitis B, and Lyme disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

mRNA therapeuticcancer immunotherapyimmuno-oncologymRNA platformEwing sarcomaUSP6 therapeuticsolid tumor treatmentintratumoral deliverypediatric oncologypreclinical biotechPriority Review VoucherPRVInvestigational New DrugINDbiotech spinout

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Merlin Biotech Comps

Public and private peers based on sector, stage, and business model.

Merlin Biotech comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Merlin Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingFeb 11, 2025
DebtNov 2, 2023
AcceleratorDec 1, 2022
GrantNov 29, 2022

Merlin Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 11, 2025

    $100K raised from The Alliance for Health Equity.

  • Nov 2, 2023

    $100K raised from Bucks Built Startup Fund.

Merlin Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Merlin Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Merlin Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersDoylestown, Pennsylvania
Year Founded2022
Last FundingFeb 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.